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Abstract
Calcium phosphate cements (CPC) are increasingly used in the orthopedic "eld. This kind of cement has potential applications in
bone defect replacements, osteosynthetic screw reinforcements or drug delivery. In vivo studies have demonstrated a good
osteointegration of CPC. However, it was also observed that the resorption of CPC could create particles. It is known from
orthopedic implant studies that particles can be responsible for the peri-implant osteolysis. Biocompatibility assessment of CPC
should then be performed with particles. In this study, we quanti"ed the functions of osteoblasts in the presence of b-TCP, brushite
and cement particles. Two particle sizes were prepared. The "rst one corresponded to the critical diameter range 1}10 lm and the
second one had a diameter larger than 10 lm. We found that CPC particles could adversely a!ect the osteoblast functions. A decrease
in viability, proliferation and production of extracellular matrix was measured. A dose e!ect was also observed. A ratio of 50 CPC
particles per osteoblast could be considered as the maximum number of particles supported by an osteoblast. The smaller particles
had stronger negative e!ects on osteoblast functions than the larger ones. Future CPC development should minimize the generation
of particles smaller than 10 lm. ( 2000 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Several calcium phosphate cements (CPC) have been
developed and have potential use in orthopedic "eld
[1}3]. Of these di!erent CPC, the type of precipitation
furnishes a classi"cation of the cement type: brushite,
hydroxyapatite, calcium-de"cient hydroxyapatite, or
amorphous calcium phosphate [4].
Calcium phosphate cements precipitating brushite
have been developed by Lemam( tre et al. for more than
10 yr [5,6]. b-Tricalcium phosphate (b-TCP) and mono-
calcium phosphate monohydrate powders are mixed
with water and dissolution}precipitation phenomenon
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induces the formation of brushite, a dicalcium phosphate
dihydrate (DCPD). Usually, these cements are prepared
with an excess of b-TCP so that the ultimate cement is
a mixture of brushite and residual b-TCP. More recently,
small quantities of hydrosoluble polymers have been
added to the mixing liquid for cement viscosity and
injectability control [7]. The injectable CPC have several
potential applications such as bone defect replacements
[1], osteosynthetic screw reinforcements [8] and drug
delivery [9].
To assess CPC biocompatibility, in vitro studies using
the cement in a bulk form [10,11] or in a very large
particle size form [12] have been performed with di!er-
ent cell types. CPC were well tolerated by the bone cells
and could enhance the production of di!erent bone pro-
teins. In vivo experiments on rabbits demonstrated that
brushite was resorbed and replaced by newly formed
bone within 3 months [2]. During CPC resorption,
particle debris were noted around the periphery of the
cement [13]. Intracellular accumulations of brushite
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Table 1
Physical and chemical characterizations of the CPC particles used. The size distribution was measured by laser di!raction (Malvern). d
10
, d
50
,
d
90
mean that 10, 50, 90% of the particles have a size smaller than the given size
Name Composition Chemical formulation Density
(g/cm3)
d
10
(lm)
d
50
(lm)
d
90
(lm)
b
L
b-TCP granules Ca
3
(PO
4
)
2
3.07 3.81 29.15 65.44
D
L
DCPD CaHPO
4
2H
2
O 2.31 3.10 14.61 38.99
C
L
Cement DCPD/b-TCP "91/9 (wt%) 2.36 1.57 28.47 74.03
b
S
b-TCP granules Ca
3
(PO
4
)
2
3.07 0.79 5.10 14.25
D
S
DCPD CaHPO
4
2H
2
O 2.31 1.03 6.35 19.50
C
S
Cement DCPD/b-TCP "91/9 (wt%) 2.36 0.55 2.51 7.52
cement were also apparent in phagocytes. In another
study, mineral grains had become detached from the
cement and some of them had been phagocytosed by
macrophages. These grains were round in shape and did
not exceed 12 lm [14].
Orthopedic implant studies have highlighted that wear
particles could induce an in#ammatory response [15,16]
or could alter the osteoblast functions [17,18] if their size
was smaller than 10 lm. It will then be important to
verify the CPC biocompatibility not only in a bulk form,
but also in a particulate form of micrometer size.
Few studies have been performed with CPC particles
smaller than 10 lm. An in vivo study using mice has
shown that CPC particles of around 10 lm could be
degraded by macrophages or multinucleated giant cells
[19]. This degradation process produced an accumula-
tion of calcium in mitochondria and "nally led to lysis of
mitochondria and cell death [19]. Very little information
is actually available on reaction of osteoblasts to CPC
particles. It has been shown that hydroxyapatite particles
smaller than 10 lm reduced osteoblast growth and alka-
line phosphatase activity [20]. The inhibition of osteo-
blast growth was con"rmed when these cells were
co-cultured with submicron calcium phosphate particles
at a concentration of 1 g/l [21]. An increase of prosta-
glandin E
2
production, a potential osteolytic factor, was
also measured [21]. If CPC particles adversely a!ect the
osteoblast functions as these studies suggested, bone
formation will be delayed until the particles are com-
pletely resorbed. Further investigations should be per-
formed to clarify the reaction of osteoblasts to CPC
particles. In particular, a dose-dependent e!ect on os-
teoblast viability or proliferation, a quanti"cation of ex-
tracellular matrix proteins production or the reaction of
osteoblasts to CPC particles of di!erent sizes should be
established. Investigations of CPC particles e!ect on
osteoblasts should also be performed in the presence of
cytokines as interleukin-6 (IL-6) or tumor necrosis fac-
tor-a (TNF-a) as these agents were detected when par-
ticles of orthopedic implants were present [22,23].
The in vitro and in vivo resorption of CPC has been
well documented allowing this material to be character-
ized as biodegradable. Bone ingrowth should also be
enhanced, or at least not altered, to quickly achieve
a stable mechanical situation. The e!ect of CPC on
osteoblasts should then be extensively detailed. Espe-
cially in the situation where particles are present, the
osteoblast functions should be quanti"ed. The aim of this
study was to assess the behavior of osteoblasts contacted
by b-TCP, brushite and cement particles. The cement
used in this study was composed of 91 wt% brushite and
9 wt% b-TCP. Two sizes of particles were prepared, one
corresponding to the critical range (1}10 lm) and the
other corresponding to a diameter larger than 10 lm.
2. Materials and methods
2.1. Calcium phosphate cement particles
2.1.1. Generation
Three powder compositions were prepared: brushite,
b-TCP and brushite cement which is a mixture of
brushite and b-TCP. Powders name and composition are
reported in Table 1. For each powder composition, two
size distributions were obtained by powder grinding and
sieving. b-TCP granules were obtained by drying a sus-
pension in a BuK chi Mini Spray Dryer 190. b-TCP powder
used in the suspension was synthesized in the laboratory
and has a Ca/P ratio of 1.47 to ensure b-TCP purity [24].
Large size granules (b
L
) were collected from the bottom
of the drying column. Small granules (b
S
) were recovered
in the collector. After drying, the granules were sintered
at 9003C for 4 h. DCPD was prepared with a commercial
powder (Fluka, ref. 21184). Large size powder (D
L
) is the
as-received commercial powder. Small size powder (D
S
)
is obtained by grinding the commercial DCPD in a ball
mill with zirconia balls in the presence of water. For this
operation, 500 ml polyethylene jar was placed in the ball
mill at 111 rpm for 2 h. Then, the powder was dried by
lyophilization. Brushite cement powders were prepared
by grinding cement blocks as explained hereafter. One
cm3 of cement paste was obtained by mixing 1.2 g
b-TCP, 0.8 g monocalcium phosphate monohydrate,
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0.015 g Na
2
H
2
P
2
O
7
and 0.8 ml H
2
SO
4
(0.1 M). b-TCP
was synthesized in the laboratory [24], monocalcium
phosphate monohydrate was purchased from Albright
& Wilson (Richmond, VA) and Na
2
H
2
P
2
O
7
was pur-
chased from Fluka (ref. 7150). Cement cylinders were
moulded in syringes. After cement setting, they were
broken manually in a mortar to obtain fragments.
Large size powder (C
L
) was prepared by grinding
manually the fragments in a mortar. Powder in the size
range between 20 and 100 lm was collected by successive
sieving and grinding operations. Small size powder (C
S
)
was prepared by grinding the fragments in a ball mill
with zirconia balls in the presence of water. For this,
500 ml polyethylene jar was placed in the ball mill at
111 rpm for 1 h. Finally, the powder was dried by
lyophilization.
2.1.2. Characterization
Powder mineralogical phase was controlled by X-ray
di!raction. X-ray di!raction measurements were per-
formed on a Siemens Kristallo#ex 805 di!ractometer, by
using the Cu-Ka line, between 20 and 403 at an angular
sweeping rate of 0.013 (2h)/s. b-TCP prepared in the
laboratory was almost pure. Commercial DCPD con-
tains a small quantity of monetite (CaHPO
4
). Theoret-
ical cement composition is 91 wt% brushite and 9 wt%
b-TCP, but a small amount of monetite was detected as
well.
Volume particle size distributions were performed with
laser di!raction by using Malvern MasterSizer equip-
ment. Fine powders have a natural tendency to agglom-
erate during storage. For this reason, the powders were
ultrasonically dispersed in water for 10 min before par-
ticle size measurements. The values obtained for the
di!erent powders are given in Table 1. Particle size and
morphology were characterized by SEM micrographs.
The di!erent powders are illustrated in Fig. 1. The
agglomeration states of the powders are also highlighted
by these pictures. b-TCP particles have a spherical
shape due to the drying technique while DCPD and
cement particles obtained by grinding present angular
shapes.
The speci"c surface area (S
BET
) of the powder was
measured by N
2
adsorption with a Micromeritics appa-
ratus using the BET model. The measured values are
summarized in Table 2. Equivalent BET diameter was
calculated from the experimental S
BET
. The agglomer-
ation factor AgF is de"ned as d
50
/d
BET
. This ratio evalu-
ates the number of particle in an agglomerate.
2.1.3. Preparation of the particles for the experiments
The particles, sterilized by gamma irradiation, were
mixed with the culture medium under sterile conditions.
Based on a particle weight to medium volume ratio,
di!erent concentrations of particles were prepared. Con-
centrations of 0.001, 0.01, and 0.1% of particles corre-
sponded to 0.01, 0.1, and 1.0 mg of particles per ml of
medium. Based on the size distribution of the di!erent
particles, the number of particles in 1 ml of the 0.1%
concentration is reported in Table 3. The particle
solutions were ultrasonicated for 10 min in a sealed
sterile container to minimize the agglomeration of the
particles before being added to the cell culture. It was
veri"ed in preliminary tests that for all the concentra-
tions used in this study, the CPC particles did not in#u-
ence the pH value of the culture medium (data not
shown).
2.2. Cell cultures
2.2.1. Osteoblast
Neonatal Sprague-Dawley calvarial rat were used to
obtain osteoblasts following the procedure reported by
Puleo [18]. The isolated osteoblasts were cultured in
monolayer at 373C and 5% CO
2
in Dulbecco’s Modi"ed
Eagle Medium (Irvine Scienti"c, Santa Ana, CA) contain-
ing 10% of fetal bovine serum (Irvine Scienti"c,), 2%
L-glutamin (BioWhittaker, Walkersville, MD) and 1% of
PSF (100], 10 000 U/ml Penicillin, 10 000 UG/ml strep-
zin, 25 UG/ml Fungizone; BioWhittaker). These cells
were characterized as being of osteoblastic phenotype by
testing for the formation of calcium phosphate salts using
the von Kossa staining technique (data not shown) which
is an indication of osteoblast mineralization [25] and by
the presence of alkaline phosphatase [18]. Osteocalcin,
another marker of osteoblast phenotype [26], was detec-
ted by EIA kit (Biomedical Technology, Stoughton, MA)
when osteoblasts were cultured with vitamin D
3
(Cal-
Biochem, San Diego, CA) (data not shown). Further-
more, the cells displayed the elongated polygonal
morphology typical of osteoblasts in culture. We checked
that the osteoblast phenotype de"ned by the above
markers was maintained until at least passage 6. Osteo-
blasts of passage 3}6 were used for the experiments. If not
otherwise indicated, cells were plated in 24 or in 96 well
plates at a concentration of 5]105 cells/cm2.
2.2.2. Fibroblasts
In order to check if the particles at low concentrations
can induce proliferation of "broblasts which can pro-
mote the creation of "brous membrane surrounding the
cement, we co-cultured "broblasts with CPC particles.
Fibroblasts from the cell line HS-68 (American Type
Culture Collection, Rockville, MD) were cultured in
monolayer at 373C and 5% CO
2
in Dulbecco’s Modi"ed
Eagle Medium (DMEM, Irvine Scienti"c, Santa Ana,
CA) containing 10% of fetal bovine serum (Irvine Scient-
i"c, Santa Ana, CA), 1% of PSF (100], 10 000 U/ml
Penicillin, 10 000 UG/ml strepzin, 25 UG/ml Fungizone;
BioWhittaker, Walkersville, MD), and 1% of non-essen-
tial amino acid (BioWhittaker, Walkersville, MD). Cells
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Fig. 1. SEM pictures of CPC particles b
L
, b
S
, D
L
, D
S
, C
L
and C
S
.
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Table 2
S
BET
, equivalent BET diameter (d
BET
) and agglomeration factor (AgF)
of the powders
Name Composition S
BET
(m2/g)
d
BET
(lm)
AgF
b
L
b-TCP granules 2.63 0.74 39.4
D
L
DCPD 1.87 1.39 10.5
C
L
Cement 3.53 0.72 39.5
b
S
b-TCP granules 2.95 0.66 7.7
D
S
DCTP 4.54 0.57 11.1
C
S
Cement 10.03 0.25 10.0
Table 3
Number of particles in 1 ml of 0.1% solution for the six di!erent
particles used
b
L
D
L
C
L
b
S
D
S
C
S
0.02]106 0.23]106 0.03]106 6.6]106 3.2]106 51.7]106
were plated in 24 well plates at a concentration of
6]103 cells/cm2.
2.3. Osteoblasts viability
The cells were collected by trypsinization and were
simultaneously double stained for 5 min at room
temperature using #uorescein diacetate and propidium
iodide stains (Sigma, St. Louis, MO) [27]. The stained
cells were examined with an inverted #uorescent micro-
scope (Nikon, Tokyo, Japan) equipped with epi-illumina-
tion (blue "lter of 495 nm and green "lter of 546 nm
allowed visualization of the green and red #uorescing
cells, respectively). The solution of stained cells was
vortexed before counting, leading to a homogeneous
distribution of green and red cells in each sample. A min-
imum of 200 viable (green)/non-viable (red) cells were
counted for each measurement. Viability was de"ned as
the ratio of viable cells to the total number of cells
[(number of green cells/(number of green#number of
red cells))].
2.3.1. Dose, size, time and composition ewects
After the osteoblasts were incubated for 4 h in 24 well
plates to recover from post-trypsinization, the medium
was removed. One ml of new medium (in control wells)
and 1 ml of various particle types solution (b
L
, D
L
, C
L
,
b
S
, D
S
, C
S
) at di!erent concentrations (0.001, 0.01, and
0.1%) were added. The cells were incubated for 24, 48,
72 h and their viability was measured.
2.3.2. Inyammatory cytokine ewects
Osteoblasts were co-incubated without (de"ning the
control group) or with CPC particles C
S
at concentra-
tions of 0.001, 0.01, and 0.1% in 96 well plates.
Two in#ammatory agents, IL-6 (Sigma, St.-Louis, MO)
and TNF-a (Sigma, St.-Louis, MO) at concentrations
1, 10, 100 ng/ml were added with the particles. The
viability of each sample was measured after 72 h of
incubation.
2.3.3. Indirect ewects
After the osteoblasts without (de"ning the control
group) or with CPC particles (b
L
, D
L
, C
L
, b
S
, D
S
, C
S
) at
0.1% concentration were incubated for 72 h, in parallel
to the viability measurement, the supernatant of each
well was individually collected and centrifuged for 5 min
at 500g (to avoid the contamination of the supernatant
by particles). A second group of osteoblasts was incu-
bated for 4 h in 24 well plates and the medium was
removed in each well. The collected supernatant from the
"rst osteoblast group was then used as the culture me-
dium. The second cell group, cultured with the condi-
tioned medium, was incubated for 72 h and its viability
was measured.
2.4. Osteoblasts proliferation
The proliferation of osteoblasts plated in 24 well plates
at a concentration of 1]104 cells/cm2 and co-cultured
for 72 h without (de"ning the control group) or with
CPC particles (b
L
, D
L
, C
L
, b
S
, D
S
, C
S
) at concentrations
of 0.001, 0.01, and 0.1% was evaluated by counting the
cells on a hemacytometer after trypsinization. The data
were normalized with the proliferation value of the con-
trol group.
2.5. Type I collagen and xbronectin mRNA expression
Osteoblasts were plated in 100 mm petri dish at a con-
centration of 5]105 cells/cm2 and incubated for 24 h.
The medium was removed and new medium without
serum was added. The incubation was continued for 24 h.
The medium deprived of serum was then removed and
0.5% serum medium without (de"ning the control group)
or with CPC particles (b
L
, D
L
, C
L
, b
S
, D
S
, C
S
) at a con-
centration of 0.01% was added to the cells and incubated
for 24 h. Relative changes in the levels of messenger RNA
(mRNA) for type I collagen and "bronectin were assessed
by Northern blot analysis. Total RNA was isolated
and puri"ed by a modi"ed guanidinium thiocyanate
phenol}chloroform extraction technique, separated by
1% agarose}formaldehyde gel electrophoresis, and
transferred onto nitrocellulose. Samples were adjusted
by assessment of 28S band intensity using ethidium
bromide so that approximately equal amounts of
total RNA were loaded into each well. Membranes were
then hybridized with cDNA probes radiolabeled by the
random primers technique, washed, and exposed to
autoradiograph "lm. Levels of mRNA were normalized
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by intensities of ethidium bromide luminescence for 28S
rRNA under UV exposure to correct for small loading
di!erences.
2.6. Alkaline phosphatase (ALP) production
ALP activity was determined using an ALP kit (Diag-
nostic kit 245, Sigma, St. Louis, MO). Cells were
plated in 24 well culture plates with 0.5 ml of complete
medium (medium described in Section 2.2.1 supple-
mented with 50 lg/ml ascorbic acid (Sigma) and 10 mM
b-glycerol phosphate (Sigma)). After 24 h, culture me-
dium was replaced by fresh media deprived of serum
without (de"ning the control group) or with CPC par-
ticles (C
L
, C
S
) at concentrations of 0.001, 0.01 and 0.1%.
The cells were cultured for another 48 h, the medium
was then removed and the cells were rinsed three times
with PBS followed by addition of 0.5 ml Triton-X 100
(1%). After freezing and thawing, the cell lysates were
sonicated for 1 min on ice. The cell lysates were centri-
fuged and a volume of 20 ll of each sample was added
to 100 ll of p-Nitrophenyl phosphate solution within
a 96 well plate at 253C and reacted for 3 min. p-Nit-
rophenol was produced in the presence of ALP and
the absorbance could be measured with a micro-
platereader at 405 nm. The change in the rate of
absorbance was directly proportional to the ALP
activity. Data were normalized by the total cell protein
measured with a commercial kit (DC protein Assay Kit,
Bio-Rad, Hercules, CA).
2.7. Fibroblasts proliferation
The proliferation of "broblasts co-cultured for 72 h
without (de"ning the control group) or with the CPC
particles (b
L
, D
L
, C
L
, b
S
, D
S
, C
S
) at concentrations of
0.001, 0.01, and 0.1% was evaluated by counting the cells
on a hemacytometer after trypsinization. The data were
normalized with the proliferation value of the control
group.
2.8. Statistical analysis
Northern blot tests were performed three times while
all the other experiments were performed three times in
triplicates, yielding essentially identical results. A one-
way ANOVA test was used to analyze the mean variance
of the data for the indirect e!ect, and the gene expression.
A two-way ANOVA test was used to analyze the mean
variance of the data for the viability, the proliferation and
the alkaline phosphatase. If statistically signi"cant di!er-
ences were found with the ANOVA test, a Fisher least
signi"cant di!erence test was performed to determine
which means were di!erent from which other means.
A 95% con"dence level was selected to de"ne signi"-
cance for all statistical tests.
3. Results
3.1. Osteoblasts viability
3.1.1. Dose, size, time and composition ewects
The viability of the osteoblasts was a!ected by CPC
particles in a dose-dependent manner (Fig. 2). The co-
culture of osteoblasts with the highest particle concen-
tration (0.1%) signi"cantly decreased viability when
compared to control and to the two lower particle
concentrations (0.001%, 0.01%) (P(0.0001). The
small CPC particle sizes (b
S
, D
S
, C
S
) were statistically
more harmful for the osteoblasts viability than the
large ones (b
L
, D
L
, C
L
) (P(0.0001). There was no e!ect
of composition between the large particle sizes, while
a statistical e!ect on osteoblasts viability existed between
the composition of the small CPC particle sizes
(P(0.05). The CPC particles C
S
were the most harmful
for the osteoblasts viability. All these observations
were veri"ed at three time points (24, 48, and 72 h)
(Fig. 2a}c).
3.1.2. Inyammatory cytokine ewects
There was no additive or direct e!ect of the two in-
#ammatory cytokines tested (IL-6, TNF-a) for 72 h on
the osteoblasts viability (Fig. 3). It was veri"ed that the
0.1% concentration of C
S
had a strong statistical e!ect
on osteoblasts viability (P(0.0001).
3.1.3. Indirect ewects
There was no statistical e!ect on osteoblast viability
using the conditioned medium (Fig. 4). No cytokine or
release of agent at a level harmful for the osteoblasts was
produced by the osteoblasts in contact with CPC par-
ticles.
3.2. Osteoblasts proliferation
A decrease of osteoblasts proliferation for all particle
types and concentrations higher than 0.001% was ob-
served compared to control (P(0.01) (Fig. 5). There was
a strong dose-dependent e!ect, the highest concentration
being the most inhibitory for the osteoblasts proliferation
(P(0.001). Except for the DCPD particles, a size e!ect
was noted, the small particle sizes being the most inhibi-
tory for the osteoblasts proliferation (P(0.02). A com-
position e!ect was noted between all but the D
L
, C
L
and
b
S
, C
S
couples (P(0.04).
3.3. Type I collagen and xbronectin mRNA expression
Turning to the gene expression, a decrease of mRNA
level for type I collagen was observed for b
S
(P(0.02)
and C
S
(P(0.0004) compared to control (Fig. 6a). A size
e!ect was noted only for the C particles (P(0.001). An
increase of mRNA level for "bronectin was observed for
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Fig. 2. Dose, size, time and composition e!ects of the CPC particles on osteoblasts viability (a) 24 h; (b) 48 h; (c) 72 h (mean value$SE). A statistical
di!erence was found between the di!erent doses, the size and the material (for details see text). The particles C
S
were the most harmful for the
osteoblasts viability (*: statistical di!erences with respect to control, n"9 and P(0.0001).
b
L
(P(0.02) compared to control (Fig. 6b). There was
a statistical decrease of mRNA level for "bronectin with
the small particle sizes (b
S
, D
S
, C
S
) compared to the large
ones (b
L
, D
L
, C
L
).
3.4. Alkaline phosphatase production
An increase in ALP production was found for particles
C
L
compared to control (Fig. 7). A concentration e!ect
was also noted (P(0.002).
3.5. Fibroblasts proliferation
The proliferation of "broblasts was inhibited by the
three small CPC particles (P(0.01) (Fig. 8). A dose
dependence was noted, the most inhibitory e!ect being
induced by the highest concentration (P(0.01).
4. Discussion
This study was performed to quantify the osteoblast
reaction contacted by di!erent types of CPC particles.
We found that the CPC particles had dose-dependent
e!ects on osteoblasts viability, proliferation, and alkaline
phosphatase production as well as on "broblasts prolifer-
ation. Particle concentrations should not exceed 0.01%,
corresponding for the C
S
particles of 50 particles per
osteoblast. There was a size e!ect on osteoblasts viability,
proliferation, and gene expression, as well as on
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Fig. 3. E!ects of in#ammatory cytokines (a) IL-6, (b) TNF-a and CPC
particles on osteoblasts viability after 72 h (mean value$SE). No
direct or additive e!ect of the two in#ammatory cytokines was found
on the osteoblasts viability (*: statistical di!erences with respect to
control, n"9 and P(0.0001).
Fig. 4. Indirect e!ect of CPC particle on osteoblasts viability using the
conditioned medium of the 0.1% culture (mean value$SE, n"9). No
indirect e!ect was noted on the osteoblasts viability using the condi-
tioned medium issued from the 72 h co-incubation of particles with
osteoblasts.
Fig. 5. Dose, size and material e!ects of the CPC particles on osteo-
blasts proliferation after 72 h (mean value$SE). A statistically signi"-
cant decrease of proliferation was found for all particle types and
concentrations (*: statistical di!erences with respect to control, n"9
and P(0.01).
"broblasts proliferation. With the parameters measured
in this study, it appeared that the small particles were less
biocompatible than the large ones. Moreover, between
the small particles, a composition e!ect was noted on the
osteoblasts viability and proliferation. The C
S
particles
were the less biocompatible. In#ammatory cytokines
seemed not to be a parameter that could in#uence these
results, at least for the osteoblasts viability.
The dose-dependent response of osteoblasts to par-
ticles has already been noted for cobalt [28] or titanium
particles [17], but was not well established for CPC
particles. The shape of the particles (round for b-TCP
and with angular shapes for the others) was not a para-
meter that in#uenced the osteoblast functions (data not
shown). The small CPC particles induced an important
negative e!ect on osteoblast functions which strongly
suggested that the phagocytosis process of CPC particles
was involved. Recent "ndings that osteoblasts phago-
cytosed Ti particles [29] and osteoblasts treated with
cytochalasin-D (agent that inhibits phagocytosis by af-
fecting actin "lament assembly of the cytoskeleton) al-
most completely suppressed the negative e!ect of Ti
particle on osteoblast viability [17] supports this hy-
pothesis. As for the macrophages or multinucleated giant
cells [19], this phagocytosis process could produce an
accumulation of calcium in mitochondria and could
eventually lead to lysis of mitochondria and cell death.
Impact of CPC particles on osteoblast functions could
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Fig. 6. mRNA expression for (a) type I collagen and (b) "bronectin of
osteoblasts in contact with CPC particles for 24 h (mean value$SE,
n"3). A decrease of mRNA level for type I collagen was observed for
the particles b
S
and C
S
, while an increase of mRNA level for "bronectin
was found for the particles b
L
(*: statistical di!erences with respect to
control, n"3 and P(0.02).
Fig. 7. Quanti"cation of ALP production normalized by the total
protein production of osteoblasts co-cultured with CPC particles
C
L
and C
S
at three concentrations for 48 h (mean value$SE). An
increase in ALP production was found for the particles C
L
at concen-
trations 0.01 and 0.1% and for the particles C
S
at concentrations 0.01%
(*: statistical di!erences with respect to control, n"9 and P(0.02).
Fig. 8. Dose, size and material e!ects of the CPC particles on "bro-
blasts proliferation after 72 h (mean value$SE). The "broblasts prolif-
eration was inhibited by the small particles (b
S
, D
S
, C
S
) and a dose e!ect
was observed (*: statistical di!erences with respect to control, n"9 and
P(0.01).
also be due to a decrease of osteoblast adhesion. Indeed,
the osteoblast is an anchorage-dependent cell. If its ad-
hesion process is perturbed, the osteoblast functions
could be a!ected. This hypothesis was based on our
recent "nding that Ti particles a!ected osteoblasts ad-
hesion [29]. From the intracellular events, CPC particles
could modify the signal pathway with a possible conse-
quence of decreasing the osteoblast functions as it was
demonstrated for Ti particles [30].
The CPC particles used in this study were shown to
modulate the gene expression of the osteoblasts. This
kind of results has already been noted for type I collagen
when osteoblast-like cells were in contact with titanium
particles [29,31]. Decrease of extracellular matrix pro-
duction could lead to a slower CPC osteointegration.
Modulation of genes expression could be caused by a re-
organization of actin "lament as shown in a study using
Ti particles [29]. In fact, the change in actin "lament
organization could in#uence the nuclear matrix architec-
ture and modulate the expression of di!erent genes as
demonstrated recently [32,33].
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The decrease of osteoblast functions in contact with
CPC used in bulk form has been documented and was
attributed to the acidi"cation of the medium due to the
dissolution of the CPC [11]. This in vitro "nding could
partially explain the fact that osteoblasts were not or very
rarely found at the cement surface during an in vivo
study performed on rabbits [14]. In the present study, the
acidi"cation of the medium could not be responsible for
the decrease of osteoblast functions as we veri"ed that
the pH value of the medium did not change for each CPC
particle concentration used. It was then the direct inter-
action of osteoblasts with particles which was involved in
the decrease of osteoblast functions.
CPC particles had no indirect e!ect on osteoblasts
viability. This result is in opposition to a previous study
using Ti particles [17]. The number and the size distribu-
tion of particles for both studies were similar. It seems
then that the chemical composition of the particles
played an important role for the conditioned medium
assay. Depending on the particles composition, an auto-
crine regulation of osteoblasts could be induced.
The proliferation of "broblasts was inhibited by CPC
particles, even at very low concentrations. In a study
using Ti particles, it has been shown that low concentra-
tions of particles could enhance "broblasts proliferation
[34]. The particles were then considered as a possible
factor for the creation of the "brous tissue surrounding
the orthopedic implants. Fibroblasts in contact with
CPC particles behaved di!erently. This could explain the
absence of "brous tissue between the cement and the
bone observed during an in vivo study [1]. Nevertheless,
it has been shown that CPC particles could stimulate the
production of potent osteolytic cytokine by "broblasts
[35].
TNF-a, which could be produced by macrophages
contacted by particles [36] and IL-6, which could be
produced by osteoblasts [37] have been shown to be
present in the surrounding of prosthesis. It was impor-
tant to verify that the results of osteoblasts viability were
not in#uenced by these in#ammatory cytokines. It
should be noted that results on viability alone did not
allow to conclude that presence of these cytokines did
not in#uence the osteoblast functions. Indeed, it would
be of interest to measure the production of di!erent
osteolytic cytokines (like prostaglandin E
2
) when par-
ticles and in#ammatory cytokines are simultaneously
present. This quanti"cation will be performed in a future
study.
Recently, some concerns have been raised about the
fact that orthopedic particles used during in vitro experi-
ments can be contaminated by endotoxin [38]. It has
also been shown that actual treatment for orthopedic
implants does not remove the endotoxin [39]. The steril-
ization procedure used in this study was not designated
to speci"cally remove the endotoxin from the particles,
but was identical as for a clinical situation. Endotoxin
could have been removed by successively treating the
particles in nitric acid and ethanolic sodium hydroxide
[35].
To verify that the loading procedure of the particles
did not induce by itself a reaction of the osteoblasts, the
particles solution was loaded in two steps in another
experiment. First, normal medium representing half of
the "nal volume was added. Then, the particle solution
representing the second half of the "nal volume was
added. This loading procedure minimized the possible
mechanical damages that the particles could induce to
the cells. When we compared the viability between the
two loading procedures, no di!erence was noted. The
e!ects of CPC particles on osteoblast functions could not
then be the result of the loading procedure.
The present study was performed on rat calvarial os-
teoblasts. This cell line is well characterized and expresses
the normal phenotypic features of osteoblast [18].
Nevertheless, extension of the present results to human
osteoblast should be done with caution. Even with hu-
man osteoblast-like cells, interaction with particles could
furnish di!erent cytotoxic results between di!erent cell
lines [28]. Results of this in vitro study should then be
considered as an indication of possible negative osteo-
blast reactions to particles that can be found in patients
treated with CPC.
Although it has been noted that small particles were
present during the process of CPC resorption [1,13,14],
no quantitative information on the particle number was
reported. Direct correlations between in vivo and in vitro
studies were then di$cult to perform. To obtain some
critical values, the CPC particle concentrations used in
this study covered three orders of magnitude. The lowest
concentration (0.001%) for the particles C
S
corresponded
to approximately 5 particles per osteoblast. This concen-
tration could be considered as a low clinical situation for
particles concentration when compared to the particles
generated from orthopedic implants [40]. Histological
studies are needed to determine the amount of particles
that are present after implantation of CPC.
5. Conclusions
The results of this study clearly established that CPC
particles could be harmful for the osteoblasts, especially
when their size was smaller than 10 lm. A decrease of
viability, proliferation and production of extracellular
matrix was measured. A dose e!ect was present, ratio of
50 CPC particles per osteoblast could be considered as
the maximum of what an osteoblast supported. The
rational for using CPC is that this material will be com-
pletely resorbed and replaced by new bone. Two pro-
cesses are simultaneously involved: (i) the degradation of
CPC performed by osteoclasts and macrophages, and (ii)
the creation of new bone performed by osteoblasts. Pres-
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ence of CPC particles could disturb the osteoblasts abil-
ity to make new bone. An unstable mechanical situation
could result if the bone formation is delayed by the
particles compared to the CPC degradation. It would
then be important for future CPC development to min-
imize the generation of particles smaller than 10 lm.
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